These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1089 related articles for article (PubMed ID: 28643625)

  • 1. Microbial Interactions and Interventions in Colorectal Cancer.
    Van Raay T; Allen-Vercoe E
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive values of colon microbiota in the treatment response to colorectal cancer.
    Galan-Ros J; Ramos-Arenas V; Conesa-Zamora P
    Pharmacogenomics; 2020 Sep; 21(14):1045-1059. PubMed ID: 32896201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics, prebiotics and colorectal cancer prevention.
    Ambalam P; Raman M; Purama RK; Doble M
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer.
    Yuan L; Zhang S; Li H; Yang F; Mushtaq N; Ullah S; Shi Y; An C; Xu J
    Biomed Pharmacother; 2018 Dec; 108():184-193. PubMed ID: 30219675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
    Fong W; Li Q; Yu J
    Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
    Kang Y; Pan W; Cai Y
    Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study Insights into Gastrointestinal Cancer through the Gut Microbiota.
    Kong F; Cai Y
    Biomed Res Int; 2019; 2019():8721503. PubMed ID: 31341907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intervention on gut microbiota may change the strategy for management of colorectal cancer.
    Taghinezhad-S S; Mohseni AH; Fu X
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1508-1517. PubMed ID: 33295040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
    Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota in autoimmunity: potential for clinical applications.
    Kim D; Yoo SA; Kim WU
    Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet, microbiota, and colorectal cancer.
    Akin H; Tözün N
    J Clin Gastroenterol; 2014; 48 Suppl 1():S67-9. PubMed ID: 25291132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.
    Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S
    Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.
    Lin C; Cai X; Zhang J; Wang W; Sheng Q; Hua H; Zhou X
    Digestion; 2019; 100(1):72-78. PubMed ID: 30332668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucins, gut microbiota, and postbiotics role in colorectal cancer.
    Pothuraju R; Chaudhary S; Rachagani S; Kaur S; Roy HK; Bouvet M; Batra SK
    Gut Microbes; 2021; 13(1):1974795. PubMed ID: 34586012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis.
    Cho M; Carter J; Harari S; Pei Z
    Clin Lab Med; 2014 Dec; 34(4):699-710. PubMed ID: 25439270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutraceuticals in colorectal cancer: A mechanistic approach.
    Rossi M; Mirbagheri SEYEDS; Keshavarzian A; Bishehsari F
    Eur J Pharmacol; 2018 Aug; 833():396-402. PubMed ID: 29935172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal microbiota and colorectal cancer: a new aspect of research.
    Koliarakis I; Psaroulaki A; Nikolouzakis TK; Kokkinakis M; Sgantzos MN; Goulielmos G; Androutsopoulos VP; Tsatsakis A; Tsiaoussis J
    J BUON; 2018; 23(5):1216-1234. PubMed ID: 30512251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.